Five Priorities for Combating Antibiotic Resistance


According to recent data from the Centers for Disease Control and Prevention, more than 2.8 million antibiotic-resistant infections occur in the United States each year, with more than 35,000 people dying as a result. The agency's "Antibiotic Threats in the United States, 2019" covers the top 18 resistant diseases and assesses progress in the fight against superbugs, which is an update of its first review of antibiotic resistance in the United States in 2013.

The following are five top priorities in the fight against antibiotic resistance:
  • Reduce antibiotic use in human medicine:  Outpatient health care settings, such as doctors' offices, emergency departments, retail health clinics, and emergency rooms, require improved antibiotic prescribing. The Joint Commission, a non-profit accrediting agency, just completed its stewardship requirement for outpatient institutions, which represents a significant step forward. Although hopeful, this rule only applies to a tiny percentage of the outpatient clinics that the association accredits.  
  • Improve animal antibiotic use: To begin, all medically significant antibiotics used in animals must be regulated by veterinarians. Despite the fact that most of these medications now require a prescription to be administered to food-producing animals as a result of a federal policy change that went into effect in 2017, some can still be acquired over-the-counter. The Food and Drug Administration announced proposed recommendations in October that would close this gap; the agency should complete it as soon as feasible. 
  • Fix the broken antibiotic market: Pew believes that economic incentives are necessary to help stimulate the discovery of antibiotics that can cure germs that are becoming increasingly resistant. This is in line with the recommendations of various studies and commissions. The Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms (DISARM) Act of 2019 should be passed by Congress, as it would alter how Medicare reimburses hospitals for treating patients with bacterial infections by removing financial barriers that prevent hospitals from using new antibiotics even when they are better able to treat a resistant infection. The federal government should establish incentives to assist pharma companies in recouping the expenses of bringing new antibiotics to market that meet unmet needs.

Comments

Post a Comment

Popular posts from this blog

Is your Immune system weak after covid?

Image
After recovering from an acute COVID-19 infection, patients may continue to experience signs and symptoms such as weariness, body aches, coughing, sore throat, breathing difficulties, and so on. In recovered patients, long Covid or Covid sequelae can arise. First, the most common side effects mentioned are fatigue or muscle weakness, dyspnea, joint pain and chest pain, sleep difficulties, anxiety or depression, and a decreased quality of life. The virus causes a cytokine storm and hyper inflammation in the immune system , which leads to additional multi-organ damage and death. Neurological issues, such as headaches, dizziness, difficulties concentrating, memory problems, diminished smell or taste, weakness, or muscle pain, affect at least one-third of patients with COVID-19. According to study, persons who recover from COVID-19 have immunity to the virus for 3 to 5 years. Immunity can develop naturally after contracting COVID-19 or as a result of receiving the COVID-19 vaccine.  ...
Read more

What are the Symptoms of Omicron- A Covid 19 Variant

Image
Research is presently being conducted all over the world in order to find this COVID variant  in fact, many research are being conducted in order to understand this variant of issue. The World Health Organization's TAG-VE, or Technical Advisory Group on Virus Evolution, named the COVID variant "Omicron" on November 26, 2021 (Friday). B.1.1.529 is the name of the new COVID variant.  Symptoms of Omicron: Most common symptoms:   Most common symptoms for the new COVID Variant “Omicron” include fever, cough, tiredness, loss of taste or smell. Less common symptoms:  Less common symptoms for the new COVID Variant “Omicron” include conditions like sore throat, headache, aches, pains, diarrhoea, a rash on skin, and discoloration of fingers or toes Serious symptoms:   Serious symptoms for the new COVID Variant “Omicron” include difficulty breathing or shortness of breath, and loss of speech or mobility, or confusion or chest pain.
Read more

What are the causes of covid-19 vaccine hesitancy?

Image
Getting a COVID-19 vaccine is a personal choice. People have already started getting vaccinated. But there is still some hesitancy to vaccines.  Vaccine Hesitancy refers to delay in acceptance for getting vaccinated or refusal of vaccines.                                                                What are the causes of covid-19 vaccine hesitancy?  Vaccine hesitancy is caused by various factors such as complacency, convenience, and confidence.  Concerns about unknown future effects, side effects, and a lack of trust are the most common reasons. Disinformation and rum ours through social media make people lose confidence. Lower levels of education and poor access to accurate information, and lack of effective public health messages or targeted campaigns is another reason for vaccine hesitancy.  Things...
Read more